Recent cases have challenged the approval of FDA’s expanded access to mifepristone, the first pill taken in a two-drug regimen to terminate pregnancy. The Supreme Court issued a decision on April 21 that maintained FDA’s approval while an appeal moves forward. Panelists will discuss the recent mifepristone cases and the impact of the legal challenges on providers in Massachusetts. (5/4/2023)
Questions? Inquiries about program materials? Contact Alan I. Johnson at ajohnson@bostonbar.org
More Episodes
Protecting Access to Abortion in a Post-Roe World
2022-07-27
98
2022-07-27
98
Strategies for Success
2022-06-10
69
2022-06-10
69
When Veterans Face Possible Bankruptcy, You Can Help
2022-06-01
46
2022-06-01
46
Public Loan Forgiveness
2022-05-23
65
2022-05-23
65
Privacy, Cybersecurity, & Digital Law
2022-05-13
52
2022-05-13
52
Charitable Board Service Connection
2022-05-11
43
2022-05-11
43
Best Practices for Effective Appellate Brief Writing
2022-05-10
109
2022-05-10
109
Charitable Board Service Workshop
2022-05-06
38
2022-05-06
38
Mass & Cass and the Crisis of Homelessness
2022-04-14
65
2022-04-14
65
AALAM Presents: Our Pathways to the Bench
2022-01-14
62
2022-01-14
62
Get this podcast on your
phone, FREE
